Beck Bode LLC’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-47,658	Closed	-$5.49M	–	124
2024 Q3	$5.49M	Buy	+47,658	New	+$5.49M	1.03%	36
2021 Q4	–	Sell	-62,740	Closed	-$6.02M	–	94
2021 Q3	$6.02M	Buy	+62,740	New	+$6.02M	1.68%	27